Axogen, Inc. AXGN 深 滬
已收盤 04-02 16:00:00 美东时间
34.44
+0.860
+2.56%
華盛通- 最 高34.555
- 今 開33.08
- 成交量 61.55万股
- 最 低 32.87
- 昨 收 33.58
- 總市值 17.87亿
- 52周最高 35.9999
- 市盈率 靜 --
- 換手率 1.19%
- 52周最低 9.215
- 委 比 -87.15%
- 總股本 5189.77万
- 歷史最高 56.85
- 量 比 0.63
- 振 幅 5.02%
- 歷史最低 1.10
- 每 手 1
- 風險率 8.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多电话会总结 ｜ Axogen(AXGN)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Axogen业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - Q4营收5,990万美元，同比增长21.3% - 全年营收2.252亿美元，同比增长20.2% - 三个核心市场均实现双位数增长 **盈利能力：** - Q4毛利润4,440万美元，毛利率74.1%（同比下降2个百分点） - 全年毛利润1.674亿美元，毛利率74.3%（同比下降1.5个百分点） - 毛利润受FDA BLA批准相关的一次性成本影响，Q4影响190万美元，全年影响占比0.9% **净利润：** - Q4净亏损1,320万美元（每股亏损0.
02-25 12:24
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
Axogen shares are trading lower after the company reported worse-than-expected Q4 EPS results.
Axogen shares are trading lower after the company reported worse-than-expected ...
02-25 03:27
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 65.0% to $12.26...
02-24 20:05
Axogen Sees FY2026 Sales $265.700M vs $259.499M Est
Axogen (NASDAQ:AXGN) sees FY2026 sales of $265.700 million vs $259.499 million analyst estimate.
02-24 20:04
Axogen Q4 Earnings Summary & Key Takeaways
Axogen (NASDAQ:AXGN) released its Q4 earnings on Tuesday, February 24, 2026 at ...
02-24 20:04
Axogen Q4 Adj. EPS $0.07 Misses $0.08 Estimate, Sales $59.904M Beat $58.870M Estimate
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is unchanged from the same period last year. The company reported quarterly
02-24 20:03
Earnings Scheduled For February 24, 2026
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
Wells Fargo Initiates Coverage On Axogen with Overweight Rating, Announces Price Target of $40
Wells Fargo analyst Larry Biegelsen initiates coverage on Axogen (NASDAQ:AXGN) with a Overweight rating and announces Price Target of $40.
02-19 21:20
